basezipper27

About

Retrospective Research involving Regorafenib Compared to TAS-102 Efficacy and Safety throughout Chemorefractory Metastatic Intestinal tract Cancer malignancy (mCRC) Sufferers: Any Multi-institution True to life Medical Information.